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Abstract Cathelin-related genes are characterized by the pres- 
ence of a prepro sequence which is highly conserved both within 
and between species. 3' RACE analysis on sheep bone marrow 
RNA, using a primer based on a conserved cathelin family coding 
region, demonstrated the presence of at least three ovine cathelin- 
related cDNAs. One of these encodes a novel prepropeptide with 
a predicted C-terminal cleavage product RGLRRLGRKIAHG- 
VKKYGPTVLRIIRIAG. The chemically synthesized form of 
this 29 amino acid peptide is shown to be a thermostable, broad 
spectrum, bactericidal agent. 
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1. Introduction 
Mammalian leukocytes play an important role in host de- 
fense against a broad spectrum of microbial pathogens. In this 
role they demonstrate multiple pathways for the uptake and 
neutralization f invading microorganisms. For example, leu- 
kocytes synthesize a variety of granule-associated peptides 
which may act individually or in concert o kill phagocytized 
microbes (for reviews see [1 3]). The combined presence of 
antimicrobial peptides as diverse in structure as cyclic dode- 
capeptide [4], cysteine-rich protegrins and defensins [2], and 
bactericidal/permeability-increasing peptide [5] may represent 
the successful evolution of in vivo antimicrobial multi-drug 
defense, which minimizes the chance of organisms developing 
resistance to individual peptides. 
Our laboratory has chosen to focus on molecular mecha- 
nisms regulating developmental expression of myeloid antimi- 
crobial peptides. Sheep are a traditional nimal model correlate 
to humans for studying biological changes occurring during 
development. For this reason, we have identified cDNA se- 
quences representing antimicrobial peptide gene families ex- 
pressed in ovine bone marrow. One such family, the cathelins, 
is characterized by the presence of mRNAs encoding a highly 
conserved N-terminal prepro sequence attached to one of a 
diverse group of C-terminal cleavage peptides [6-12]. We report 
here the identification of ovine bone marrow-derived, cathelin- 
related cDNA sequences. One of these sequences encodes a 
novel prepropeptide with a putative C-terminal 29 amino acid 
peptide we have termed SC5. Chemical synthesis of SC5 and 
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The nucleotide sequence data reported in this paper have been regis- 
tered in the EMBL Nucleotide Sequence Database under accession 
numbers X92758 for SC5-I and X92757 for SC5-2. 
subsequent testing in vitro shows it to be a potent, broad- 
spectrum antimicrobial peptide. 
2. Materials and methods 
2.1. Bone marrow RNA isolation and 3' RACE analysis 
Ovine bone marrow RNA was isolated from an adult iliac crest 
sample by the procedure of Chomczynski and Sacchi [13]. 3' rapid 
amplification feDNA ends (3' RACE) was performed on 5/~g of bone 
marrow total RNA using the 3' RACE System (Gibco BRL, Grand 
Island, NY). The gene specific primer (SHI: 5' ATGGAGACCCGG- 
GCCAGCCT 3') was based on the conserved initial coding sequences 
of cathelin family cDNAs. 3' RACE PCR products were blunt end 
ligated into the pCR-Script SK(+) blunt-end vector (Stratagene, La
Jolla, CA) and transfected into E. eoli Sure cells (Stratagene). Ampi- 
cillin-resistant colonies containing plasmids with cathelin-related in- 
serts were identified by hybridization with a second oligonucleotide 
(Sh2: 5' GCACGGCCTCCCTGTAGCTGAGGGC 3') whose se- 
quence was based on coding nucleotides 91-115 of PR39 [14]. 
2~2. Sequencing of cathelin-related cDNAs 
Colonies hybridizing to the Sh2 probe were grown as 3 ml minipreps, 
plasmid DNA isolated, and inserts equenced using the T3 and T7 
primers flanking the cloning site as well as internal primers. In deter- 
mining the initial coding sequences for eDNA SC5-1 we sequenced the 
corresponding region of the SC5-1 gene (data not shown). Sequences 
were compared to the GenBank database using the GCG version 7 
program (Genetics Computer Group Inc., Madison, WI). 
2.3. Synthesis of SC5 peptide 
The 29 amino acid peptide SC5 was synthesized commercially b  
Quality Controlled Biochemicals (Hopkinton, MA) using solid phase 
Fmoc chemistry, and purified by RP-HPLC on a YMC ODS, 12 ¢tm 
particle size, and a 120 ~ pore size (YMC, Wilmington, NC). The mass 
of 3256 Da was verified by mass spectroscopy using a Voyager 
MALDI-TOF (Perseptive Biosys., Framingham, MA). 
2.4. Analysis of SC5 antimierobial activity 
The chemically synthesized SC5 peptide was resuspended in sterile 
water and used irectly for antimicrobial ssays as described inthe text. 
Initial antimicrobial ssays were performed using the phoP mutant of 
Salmonella typhimuriurn [15] due to its increased sensitivity o antimi- 
crobial peptides. 
3. Results 
3' RACE analysis on adult sheep bone marrow RNA, using 
a primer based on conserved cathelin sequences, produced 
PCR products of approximately 600 base pairs in length. The 
products were gel-purified and blunt-end ligated into the pCR- 
Script vector. Plasmids containing a cathelin-related insert 
were identified by hybridization with a nested second oligonu- 
cleotide, representing additional sequences conserved within 
the cathelin gene family. Among the twelve hybridizing colonies 
characterized the 5' sequences of all eDNA inserts demon- 
strated a high degree of conservation (data not shown), while 
the 3' sequences demonstrated significant diversity. Three of 
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Fig. 1. Nucleotide and deduced amino acid sequences tbr the SC5- 
encoding 3' RACE products SC5-1 and -2. Nucleotide numbering is 
along the right margin. SC5-1 eDNA sequence ispresented, with single 
letter amino acid codes directly above in italics. Nucleotide substitu- 
tions and subsequent amino acid changes present in the SC5-2 sequence 
are indicated below' the SC5-1 sequence. The initial 23 nucleotides of 
coding sequence could not be determined from the 3' RACE analysis 
as the primer Shl spanned that region. Therefore, we determined the 
sequence of this region from the cloned SC5-1 gene. Predicted C-termi- 
nal cleavage product SC5 is underlined, as is the polyA addition signal 
sequence. 
twelve inserts encoded a peptide homologous to the bovine 
BAC5 [9], four encoded a peptide homologous to the bovine 
cyclic dodecapeptide [4], and the remaining five inserts encoded 
a unique peptide labeled SC5. Two SC5-encoding cDNA in- 
serts (SC5-1 and -2)were sequenced in their entirety on both 
strands {Fig. 1). SC5-2 differed from SC5-1 by 10 nucleotide 
substitutions resulting in six amino acid substitutions. 
Analysis of the prepropeptide encoded by the SC5 cDNAs 
demonstrated a classical cathelin-like prepro region (Fig. 2). 
Based on the known valine processing site for such cathelin 
family members as the protegrins [16], PM23 [10], PR39 [14], 
BAC7 [11], and indolicidin [12] we predicted that the C-terminal 
cleavage product SC5 would be a 29 amino acid peptide with 
the sequence RGLRRLGRKIAHGVKKYGPTVLRI IR IAG.  
Preliminary analysis suggested that this peptide could assume 
Table 1 
Antibacterial activity of SC5 
Organism (ATCC no.) Minimal inhibitory concentration 
(,ug/ml) 
Staphylococcus aureus (25923) 5 10 
Pseudomonas eruginosa (27853) 5 10 
Klebsiella pneumoniae (13883) 2.5 5 
Candida albicans (14053) 10 -25 
Single colonies of the indicated microorganisms were incubated in TSB 
at 37°C overnight. 2.5 x 104 cells were added to 0.2 ml of 0.25% TSB 
in individual wells of a 96 well microtiter plate. SC5 was added at 
concentrations of 2.5-50 ¢tg/ml. Cells grown in the absence of SC5 
served as a control. After incubation for 16 h at 37°C, O.D. 600 
absorbance was used to determine relative cell numbers. 
an amphipathic a-helical structure, similar to that of the linear 
magainin [17] and cecropin [18] peptides, and therefore might 
demonstrate antimicrobial properties. 
Chemical synthesis of the SC5 peptide allowed us to address 
the following questions: (1) was it an antibacterial agent; 
(2) was it thermostable; (3) was it bactericidal; and (4) did it 
demonstrate a broad spectrum of antimicrobial activity? 
The phoP mutant strain of S. typhimurium was chosen for 
our initial assay bacterium due to its relative sensitivity to 
antimicrobial peptides [15]. Fig. 3 shows that this strain is 
sensitive to SC5 in a plate assay and that preincubation of the 
peptide at 65°C does not alter the antibacterial effect. Figure 
4 presents the results of a standard assay for bactericidal activ- 
ity again using the phoP Salmonella mutant strain. SC5 showed 
significant cidal activity at concentrations a low as 1/lg/ml (0.3 
//M/l). 
Finally, a panel of Gram (+), Gram (-),  and fungal organ- 
isms all demonstrated sensitivity to SC5 (Table 1) at minimal 
inhibitory concentrations comparable to those shown for the 
magainin and fl-defensin peptides [19]. 
4. Discussion 
A wealth of cathelin gene family cDNA and peptide data has 
contributed to our understanding of the complexity of myeloid- 
specific antimicrobial agents. A remarkable feature of this gene 
family is the degree of amino acid and nucleic acid conservation 
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Fig. 2. The SC5 prepropeptide is a member of the cathelin gene thmil}. Amino acid sequence alignment of the pig cathelin peptide [10], bovine cyclic 
dodecapeptide [4], bovine BAC5 [9], bovine indolicidin [12], and SC5 prepropeptides demonstrates the inter-species conservation present in the prepro 
piece. The predicted hydrophobic signal peptide includes the first 29 residues, while the anionic pro piece includes 101 amino acids in the bovine 
sequences and 102 amino acids in the sheep sequence. Mature peptide regions are presented in italics along with the predicted SC5 sequence. Initial 
eight amino acids of the SC5-1 prepropeptide were derived from the gene sequence. 
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present in the prepro region of genes both within a species and 
between species (pig, human, bovine, and rabbit) (reviewed [2]). 
We and others [7,10] have utilized this sequence conservation 
to construct oligonucleotide primers useful in isolating cDNAs 
encoding novel family members. The identification of a eDNA 
encoding sheep peptide SC5, a new and potent broad spectrum 
antimicrobial agent, attests to the valuable information which 
can be obtained via this approach. 
The predicted SC5 29 amino acid peptide belongs to the 
family of cationic, cysteine-free, amphipathic peptides which 
have been characterized extensively in the case of the Xenopus 
magainins and the insect cecropins [3]. The presence of a termi- 
nal glycine could indicate that C-terminal amidation is involved 
in the final peptide product. The antimicrobial properties of 
SC5 demonstrated in this work are consistent with this agent 
acting as a broad-spectrum, bactericidal agent in vivo. In eval- 
uating the amino acid structure of SC5, the presence of poten- 
tial dibasic amino acid endopeptidase sites at positions 4 5, 
8-9, and 15-16 of SC5 suggests that cleavage at one or more 
of these positions may be involved either in the production of 
a smaller mature peptide or as a mechanism for terminating 
SC5 activity. Antimicrobial assays involving shortened versions 
of SC5 will be of interest in this regard. A future direction of 
our research will be the documentation of possible SC5 process- 
ing in vivo utilizing SC5-specific antisera. 
The presence of highly conserved prepro sequences in genes 
encoding markedly differing mature peptides predicts that this 
prepro piece plays an important functional role in the biology 
of the expressing cell type. Mutational analyses, such as those 
reported for the human defensin prepro sequence [20], should 
contribute to our knowledge of the functional significance of 
the conserved region. Additionally, lhe results of cathelin fam- 
ily chromosomal mapping studies as well as gene structure 
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Fig. 4. Bactericidal effect of SC5. A single colony of the phoP mutant 
of S. typhimurium was grown overnight in trypticase soy broth (TSB) 
at 37°C. Mid-logarithmic cells were obtained by subculturing and incu- 
bating for an additional 4 h at 37°C. l x 106 cells were added to 100 ¢tl 
of 10 mM sodium phosphate buffer, pH 7.4, and incubated for 2 h at 
37°C in the presence of SC5. Cells incubated in the absence of SC5 
served as an internal control. Dilutions were made of each sample and 
were plated on LB agar overnight at 37°C. Activity is expressed as logj0 
reduction in CFU/ml. 
analysis may aid in suggesting the nature of the genetic mecha- 
nisms responsible for the derivation of this multigene family 
[14,161. 
Investigating the structure of genes encoding myeloid anti- 
microbial peptides uch as SC5 may lead to the identification 
of mechanisms for pharmacological regulation of their expres- 
sion. Augmentation of endogenous host defense mechanisms, 
especially in immature or immune-compromised individuals, 
may prove to be beneficial in combating multi-drug resistant 
microorganisms. 
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Fig. 3. SC5 activity detected using a well diffusion assay. Thin (l mml 
plates (0.5% tryptone, 0.75% agarose) were seeded with mid-logarith- 
mic cells of the phoP mutant S. typhimurium. 2 mm diameter wells were 
created in the agarose and 2~1 of SC5 samples dissolved in sterile water 
were pipetted. Plates were incubated for 14 18 h at 37°C and activity 
was measured as the radius of the clearing zone. The single top well is 
a water control; middle and bottom wells are 2 ug//~l SC5 peptide 
samples incubated for 30 min at 65 and 37°C, respectively. 
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